The presence of chronic inflammation in cancer patients has been held responsible for the induction of MDSC via growth factors and cytokines (e.g. G- or GM-CSF, IL-6, TGFβ, PGE2) acting via ERK/mTOR, STAT, NFκB and SMAD signaling pathways [49, 50]. Here, NFKB1 is linked to cancer.